Karyopharm Therapeutics(KPTIQ)
$0.020.00 (0.00%)
KPTIQ
Karyopharm Therapeutics ownership
$0.02
At close:0.00 (0.00%)
Want to see KPTIQ full AI Analyst Report?
Karyopharm Therapeutics (KPTIQ) Ownership - Who Owns Karyopharm Therapeutics?
1,274 Followers
Karyopharm Therapeutics (KPTIQ) Ownership Overview
- 3.63% Insiders
- 19.83% Mutual Funds
- 1.64% Other Institutional Investors
- 5.09% ETFs
- 69.81% Public Companies and Individual Investors
The ownership structure of Karyopharm Therapeutics (KPTIQ) stock is a mix of institutional, retail, and individual investors. Approximately 26.56% of the company’s stock is owned by Institutional Investors, 3.63% is owned by Insiders, and 69.81% is owned by Public Companies and Individual Investors.
The ownership structure of Karyopharm Therapeutics (KPTIQ) stock is a mix of institutional, retail, and individual investors. Approximately 26.56% of the company’s stock is owned by Institutional Investors, 3.63% is owned by Insiders, and 69.81% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Peter Kolchinsky | 1,917,354 | Institution | 8.45% | 32,595 |
| BlackRock, Inc. | 1,418,799 | Institution | 6.26% | 24,120 |
| Mutual Fund Series Trust | 1,125,000 | Institution | 4.96% | 19,125 |
| Vanguard | 1,076,752 | Institution | 4.75% | 18,305 |
| Vanguard Index Funds | 940,813 | Institution | 4.15% | 15,994 |
| Delaware Group Equity Funds Iv | 566,666 | Institution | 2.50% | 9,633 |
| T. Rowe Price Small-cap Value Fund, Inc. | 435,070 | Institution | 1.92% | 7,396 |
| Tiaa-cref Funds | 429,563 | Institution | 1.89% | 7,303 |
| Richard A. Paulson | 269,747 | Insider | 1.19% | 4,586 |
| Fidelity Salem Street Trust | 242,385 | Institution | 1.07% | 4,121 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Mutual Fund Series Trust | 1,125,000 | Institution | 4.96% | 19,125 |
| Vanguard Index Funds | 940,813 | Institution | 4.15% | 15,994 |
| Delaware Group Equity Funds Iv | 566,666 | Institution | 2.50% | 9,633 |
| T. Rowe Price Small-cap Value Fund, Inc. | 435,070 | Institution | 1.92% | 7,396 |
| Tiaa-cref Funds | 429,563 | Institution | 1.89% | 7,303 |
| Fidelity Salem Street Trust | 242,385 | Institution | 1.07% | 4,121 |
| Fidelity Concord Street Trust | 184,450 | Institution | 0.81% | 3,136 |
| Fidelity Commonwealth Trust Ii | 169,383 | Institution | 0.75% | 2,880 |
| Vanguard Scottsdale Funds | 134,149 | Institution | 0.59% | 2,281 |
| Bridgeway Funds, Inc. | 71,873 | Institution | 0.32% | 1,222 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Total Stock Market ETF, VTI ETF | 677,729 | Institution | 2.99% | 826,829 |
| Vanguard Extended Market ETF, VXF ETF | 263,084 | Institution | 1.16% | 320,962 |
| Vanguard Russell 2000 ETF, VTWO ETF | 115,379 | Institution | 0.51% | 140,762 |
| CHNA | 42,012 | Institution | 0.19% | 44,533 |
| Vanguard Russell 2000 Value ETF, VTWV ETF | 15,578 | Institution | 0.07% | 19,005 |
| Vanguard Russell 2000 Growth ETF, VTWG ETF | 3,212 | Institution | 0.01% | 3,919 |
| Vanguard Russell 3000 ETF, VTHR ETF | 1,733 | Institution | <0.01% | 2,114 |
| Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD, GB:VRSD ETF | 37 | Institution | <0.01% | 45 |
FAQ
Who Owns Karyopharm Therapeutics (KPTIQ)?
According to the latest TipRanks data, approximately 26.56% of the company's stock is held by institutional investors, 3.63% is held by insiders, and 69.81% is held by public companies and individual investors.
What percentage of Karyopharm Therapeutics (KPTIQ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 26.56% of Karyopharm Therapeutics (KPTIQ) stock is held by institutional investors: 19.83% by mutual funds, 5.09% by ETFs and 1.64% by other institutional investors.
What percentage of Karyopharm Therapeutics (KPTIQ) stock is held by retail investors?
According to the latest TipRanks data, approximately 69.81% of Karyopharm Therapeutics (KPTIQ) stock is held by public companies and individual investors.
Who owns the most shares of Karyopharm Therapeutics (KPTIQ)?
Peter Kolchinsky owns the most shares of Karyopharm Therapeutics (KPTIQ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
